Multiple sclerosis I

Published on 10/04/2015 by admin

Filed under Neurology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1613 times

Multiple sclerosis I

Multiple sclerosis (MS, disseminated sclerosis) is a common disorder affecting about 1 in 1000 individuals in the UK. It is a major cause of disability in young adults. The diagnosis of MS requires two separate episodes of central nervous system demyelination separated in space and time.

Pathophysiology

The area of demyelination disrupts the conduction of a nerve impulse (Fig. 2). This initially blocks conduction, but with recovery conduction is slowed and the refractory period is prolonged. Conduction along such segments is particularly sensitive to temperature changes and may fail if the temperature rises (which leads to Uhtoff’s phenomenon; see below).

Symptoms and signs

Measuring disability

MS is a very variable disease. To try to assess treatment, it is imperative to have a reliable and valid measure of disability. This is straightforward for single components of disability, for example acuity and field, in assessing visual recovery after optic neuritis. A scale to cover the multiple possible disabilities found in MS will inevitably be less reliable: the most frequently used scale is the Kurtzke disability status scale (Box 1). This uses mobility as the major determinant. The scale is not linear (a one-point change means different things at different points on the scale) and has limited reliability. It is, however, the scale used in all recent major trials.